Statement Of Cash Flows

Kohjin Bio Co., Ltd. - Filing #7320495

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
1,321,461,000 JPY
922,994,000 JPY
Interest and dividends received
832,000 JPY
641,000 JPY
Interest paid
-23,238,000 JPY
-32,434,000 JPY
Income taxes paid
-475,375,000 JPY
-430,048,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Net cash provided by (used in) operating activities
823,681,000 JPY
461,153,000 JPY
Cash flows from investing activities
Purchase of securities
JPY
-9,999,000 JPY
Purchase of property, plant and equipment
-562,554,000 JPY
-560,664,000 JPY
Net cash provided by (used in) investing activities
-577,354,000 JPY
-575,459,000 JPY
Loan advances
JPY
-7,000,000 JPY
Proceeds from collection of loans receivable
JPY
7,000,000 JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Proceeds from short-term borrowings
600,000,000 JPY
600,000,000 JPY
Repayments of short-term borrowings
-300,000,000 JPY
-300,000,000 JPY
Proceeds from long-term borrowings
750,000,000 JPY
JPY
Dividends paid
-79,135,000 JPY
-41,650,000 JPY
Repayments of long-term borrowings
-939,800,000 JPY
-409,600,000 JPY
Net cash provided by (used in) financing activities
-1,348,000 JPY
-172,209,000 JPY
Effect of exchange rate change on cash and cash equivalents
19,392,000 JPY
14,593,000 JPY
Net increase (decrease) in cash and cash equivalents
264,369,000 JPY
-271,921,000 JPY
Cash and cash equivalents
1,726,936,000 JPY
1,462,566,000 JPY
1,734,488,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.